MOKARI ATABAK (Chief Financial Officer) sold 83.2% of their position (80K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $9.18M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+80K
Price / share
$23.06
Trade value
$1.84M
% of position
Common Stock
Shares
−4.20K
Price / share
$105.54
Trade value
$443.25K
% of position
Common Stock
Shares
−8.96K
Price / share
$106.96
Trade value
$957.89K
% of position
Common Stock
Shares
−400.00
Price / share
$108.46
Trade value
$43.38K
% of position
Common Stock
Shares
−2.20K
Price / share
$110.03
Trade value
$242.28K
% of position
Common Stock
Shares
−600.00
Price / share
$110.95
Trade value
$66.57K
% of position
Common Stock
Shares
−4.70K
Price / share
$113.18
Trade value
$531.94K
% of position
Common Stock
Shares
−15.48K
Price / share
$114.96
Trade value
$1.78M
% of position
Common Stock
Shares
−14.22K
Price / share
$115.87
Trade value
$1.65M
% of position
Common Stock
Shares
−7.09K
Price / share
$116.96
Trade value
$829.10K
% of position
Common Stock
Shares
−8.27K
Price / share
$117.93
Trade value
$974.95K
% of position
Common Stock
Shares
−4.78K
Price / share
$118.73
Trade value
$567.91K
% of position
Common Stock
Shares
−8.10K
Price / share
$119.95
Trade value
$971.94K
% of position
Common Stock
Shares
−1K
Price / share
$120.67
Trade value
$120.80K
% of position
Net shares
+0.00
Net value
-$7.33M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +80K | $23.06 | $1.84M | 496.0% | 16.13K | 96.13K |
| Common Stock Direct | 7/30/2026 | S · Sale | −4.20K | $105.54 | $443.25K | 4.4% | 96.13K | 91.93K |
| Common Stock Direct | 7/30/2026 | S · Sale | −8.96K | $106.96 | $957.89K | 9.7% | 91.93K | 82.97K |
| Common Stock Direct | 7/30/2026 | S · Sale | −400.00 | $108.46 | $43.38K | 0.5% | 82.97K | 82.57K |
| Common Stock Direct | 7/30/2026 | S · Sale | −2.20K | $110.03 | $242.28K | 2.7% | 82.57K | 80.37K |
| Common Stock Direct | 7/30/2026 | S · Sale | −600.00 | $110.95 | $66.57K | 0.7% | 80.37K | 79.77K |
| Common Stock Direct | 7/30/2026 | S · Sale | −4.70K | $113.18 | $531.94K | 5.9% | 79.77K | 75.07K |
| Common Stock Direct | 7/30/2026 | S · Sale | −15.48K | $114.96 | $1.78M | 20.6% | 75.07K | 59.59K |
| Common Stock Direct | 7/30/2026 | S · Sale | −14.22K | $115.87 | $1.65M | 23.9% | 59.59K | 45.37K |
| Common Stock Direct | 7/30/2026 | S · Sale | −7.09K | $116.96 | $829.10K | 15.6% | 45.37K | 38.28K |
| Common Stock Direct | 7/30/2026 | S · Sale | −8.27K | $117.93 | $974.95K | 21.6% | 38.28K | 30.02K |
| Common Stock Direct | 7/30/2026 | S · Sale | −4.78K | $118.73 | $567.91K | 15.9% | 30.02K | 25.23K |
| Common Stock Direct | 7/30/2026 | S · Sale | −8.10K | $119.95 | $971.94K | 32.1% | 25.23K | 17.13K |
| Common Stock Direct | 7/30/2026 | S · Sale | −1K | $120.67 | $120.80K | 5.8% | 17.13K | 16.13K |
| Total | +0.00 | -$7.33M | ||||||
Stock option (right to buy)
Common Stock
80K shares
Shares
−80K
Strike price
23.06
Held after
95.83K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock80K shares | 7/30/2026 | M · Option Exercise | −80K | 23.06 | — | 95.83K |